
hayaship/iStock via Getty Images
Shares of Canopy Growth (NASDAQ:CGC) were on track for their seventh straight session of losses on Monday, as the stock fell more than 3.6% to $1.20 in afternoon trade.
The Canada-based cannabis company has lost more than 18% in the preceding six trading sessions. The stock has lost more than 55% so far this year, compared to a 1.47% gain in the broader S&P 500 Index.
CGC is down 34% over the past one month. The stock closed 3.88% lower on Friday, at $1.24.
Shares of Canopy Growth have been declining since the cannabis player reported its Q4 results for fiscal 2025, falling well short of Street forecasts as its international operations and Storz & Bickel segment underperformed.
The Ontario-based company reported C$65.0M in net revenue for the quarter, missing the consensus by $5.5M, even as Canopy’s Canadian segment offset a sharp decline in the other segments.
Seeking Alpha analyst Alan Brochstein reinforced his Strong Sell rating in a recent analysis and pointed out that Canopy Growth’s Q4 results were dismal, with revenue and EBITDA missing expectations.
“The company continues to dilute shareholders through aggressive share issuance, and its tangible book value per share has dropped significantly,” Brochstein added.
Seeking Alpha’s Quant rating system has rated CGC HOLD, while SA authors and sell-side analysts have rated the stock SELL.
More on Canopy Growth Corporation
- Sell The Canopy Growth Bounce
- Sentiment Sours On Canopy Growth As It Reports High Net Loss And Lower Revenues
- Canopy Growth Corporation (CGC) Q4 2025 Earnings Call Transcript
- Canopy Growth targets $20M cost reductions and margin improvement amid organizational overhaul
- Canopy Growth Q4 Preview: What to expect?